<DOC>
	<DOCNO>NCT02540005</DOCNO>
	<brief_summary>The main purpose study analyse on-going coagulation process aSAH . For investigation investigator use rotational thromboelastometry ( ROTEM ) point-of-care test use variety activator provide target dynamic analysis coagulation cascade . This prospective , observational clinical study do 16 aSAH patient treat Tampere University Hospital intensive care unit 16 control patient ( elective craniotomy due non-ruptured intracranial aneurysm .</brief_summary>
	<brief_title>Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Age ≥ 18 year Acute subarachnoid haemorrhage ( confirm compute tomography , CT , cerebrospinal fluid erythrocyte count 1000 x 106/l ) AND confirm origin either compute angiography ( CTA ) digital subtraction angiography ( DSA ) Onset symptom ≤ 12 hour Expected stay 72 hour ICU Pregnancy Any longterm anticoagulant medication , except lowdose aspirin ( &lt; 150 mg/day ) Known active cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>